Stay updated on SEA-CD70 Safety in Myeloid Malignancies Clinical Trial

Sign up to get notified when there's something new on the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page continues to show the version history for the clinical trial record, including submission dates and the sections updated in each version.
    Difference
    0.1%
    Check dated 2026-11-08T04:30:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:37:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    0.4%
    Check dated 2026-10-25T01:36:20.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:12:57.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:50:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.7.0 entry, replacing the previous Revision: v3.6.6. This reflects an underlying platform update to the page history interface rather than changes to the study record content.
    Difference
    0.1%
    Check dated 2026-09-20T00:36:12.000Z thumbnail image

Stay in the know with updates to SEA-CD70 Safety in Myeloid Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page.